Outcome of the Meeting of Board of Directors held on Wednesday, 02nd September, 2026.

GENPHARMASEC LIMITED Date: 02.09.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Outcome of the Meeting of Board of Directors held on Wednesday, 02"! September, 2026. Dear Sir/Ma’am, Pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III of the said Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Wednesday, 024 September, 2026, inter alia, has considered and approved the following items: 1. Fixed the Day, Date, Time and Mode of 34 Annual General Meeting (AGM) of the company as Tuesday, 29'* September, 2026 at 11:00 A.M. through Video Conferencing (VC) or Other Audio Visual Means (OAVM) and approved the Draft Notice & Calendar of Events for the same. 2. Fixed the Cut-off date i.e Tuesday, 2294 September, 2026 to determine the entitlement of voting rights of members for E-voting and fixed commencement and closing date for E-voting i.e. Saturday, 26 September, 2026 (9:00 a.m. IST) and ends on Monday, 28 September, 2026 (5:00 p.m. IST). 3. Considered and Approved the Director’s Report for the Financial Year ended 31*t March, 2026. 4. Considered and Approved the Annual Report for Financial Year 2025-26. 5. Considered and approved the period of closure of the Share Transfer Book and the Member's Registers of the Company, In Compliance with the provisions of Section 91 of Companies Act, 2013 and Regulation 42 of the listing regulations, from Wednesday, 23™ September, 2026 to Tuesday, 29'» September, 2026 (Both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on 29 September, 2026. 6. Considered and approved the appointment of M/S. Jaymin Modi & Co., Practicing Company Secretaries as the Scrutinizer of the 34 Annual General Meeting of the Company, to scrutinize the e-voting and remote e-voting process in a fair and transparent manner. 7. Considered and approved the Re-appointment of Mr. Sohan Chaturvedi (DIN:-09629728) as Whole Time Director of the Company, subject to approval of shareholders. 8. Considered and approved the advances any loan/give guarantee/provide security u/s 185 of the companies act, 2013, subject to approval of the shareholders. We further inform you that the Board Meeting commenced at 03:00 pm today and concluded at 03:30 pm. 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com Be +91-86555 50242 Dd www.genpharmasec.com CIN : L24231MH1992PLC323914 GENPHARMASEC LIMITED The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure) Requirements 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 along with brief profiles of Directors, being appointed/re-appointed are provided as Annexure-A. Kindly take the same on records for your perusal. Thanking you, For Genpharmasec Limited SOHAN SGHAN CHATURVED CHATU RVE DI Date: 2026.09.02 15:39:52 +05'30' Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance @genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com gq +91-86555 50242 Dd www.genpharmasec.com CIN : L24231MH1992PLC323914 GENPHARMASEC LIMITED Annexure-A Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 Sr. No. | Particulars Description 1. Name of the Director Mr. Sohan Chaturvedi (DIN: 09629728) . Reason for change Re-Appointment 3. Effective Date of appointment 26‘ April, 2027 & Re-Appointment as a Whole Time Director of Term of appointment the Company for a term of 3 years w.e,f 26 April, 2027 subject to the approval of the shareholders. 4. Brief Profile Mr. Sohan Chaturvedi has done Bachelor of Commerce and master of commerce from Agra university and having 17 years of experience and expertise in the areas of finance & accounting. 5. Disclosure of relationships between | None Directors (in case of appointment as a Director). 6. Information as required pursuant to} Mr. Sohan Chaturvedi not debarred from BSE Circular with ref. no. | holding the office of Director by virtue of any LIST/COMP/14/2018-19 and the | SEBI Order or any other such authority. National Stock Exchange of India Ltd with ref. no. NSE/CML/2018/24, dated 20 June 2018 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance @genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com gz) +91-86555 50242 Dd www.genpharmasec.com CIN : L24231MH1992PLC323914